Serum amyloid A (SAA) as a predictive marker for severity and morbidity from COVID-19

Dr. Pouw explores the relevance and value of serum amyloid A (SAA) and other inflammation markers in the management of hospitalized COVID-19 patients. The impact of the evolving SARS-CoV-2 variants as well as the degree of progression of COVID-19 on inflammation markers and patient management are analyzed and reviewed.

Nadine Pouw, Franciscus, Gasthuis & Vlietland

Dr. Nadine Pouw
Franciscus, Gasthuis & Vlietland